Bone or cartilage mass other diagnostic studies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Mahshid |
||
| (6 intermediate revisions by one other user not shown) | |||
| Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
Bone scintigraphy may be helpful in the diagnosis of bone and cartilage tumors. Radioisotopes play an important role in the diagnosis | Bone scintigraphy may be helpful in the diagnosis of bone and cartilage tumors. [[Radioisotopes]] play an important role in the differential diagnosis between benign and malignant bone lesions.<ref name="pmid9652512">{{cite journal |vauthors=Focacci C, Lattanzi R, Iadeluca ML, Campioni P |title=Nuclear medicine in primary bone tumors |journal=Eur J Radiol |volume=27 Suppl 1 |issue= |pages=S123–31 |year=1998 |pmid=9652512 |doi= |url=}}</ref><ref name="pmid24848845">{{cite journal |vauthors=Costelloe CM, Chuang HH, Madewell JE |title=FDG PET/CT of primary bone tumors |journal=AJR Am J Roentgenol |volume=202 |issue=6 |pages=W521–31 |year=2014 |pmid=24848845 |doi=10.2214/AJR.13.11833 |url=}}</ref> | ||
==Other Diagnostic Studies== | ==Other Diagnostic Studies== | ||
| Line 11: | Line 11: | ||
===Bone Scintigraphy=== | ===Bone Scintigraphy=== | ||
*Bone scintigraphy may be helpful in the diagnosis of bone and cartilage tumors | *Bone scintigraphy may be helpful in the diagnosis of bone and cartilage tumors | ||
*Radioisotopes play an important role in the diagnosis of benign and malignant bone lesions<ref name="pmid9652512">{{cite journal |vauthors=Focacci C, Lattanzi R, Iadeluca ML, Campioni P |title=Nuclear medicine in primary bone tumors |journal=Eur J Radiol |volume=27 Suppl 1 |issue= |pages=S123–31 |year=1998 |pmid=9652512 |doi= |url=}}</ref> | |||
*Bone scintigraphy is primarily used to help diagnose a number of conditions related to bone or cartilage masses, including: primary bone tumors, secondary bone tumors, locating some sources of bone inflammation | *Bone scintigraphy is primarily used to help diagnose a number of conditions related to bone or cartilage masses, including: primary bone tumors, secondary bone tumors, locating some sources of bone inflammation | ||
*Bone scintigraphy features, include:<ref name="pmid9652512">{{cite journal |vauthors=Focacci C, Lattanzi R, Iadeluca ML, Campioni P |title=Nuclear medicine in primary bone tumors |journal=Eur J Radiol |volume=27 Suppl 1 |issue= |pages=S123–31 |year=1998 |pmid=9652512 |doi= |url=}}</ref> | *Bone scintigraphy features, include:<ref name="pmid9652512">{{cite journal |vauthors=Focacci C, Lattanzi R, Iadeluca ML, Campioni P |title=Nuclear medicine in primary bone tumors |journal=Eur J Radiol |volume=27 Suppl 1 |issue= |pages=S123–31 |year=1998 |pmid=9652512 |doi= |url=}}</ref> | ||
:*Characterization of bone malignancy | :*Characterization of [[Bone malignancies|bone malignancy]] | ||
:*Characterization of pathological fractures | :*Characterization of [[Fracture|pathological fractures]] | ||
:*Technetium-99m methylene diphosphonate (Tc-99m MDP) is the isotope of choice | :*[[Technetium-99m|Technetium-99m methylene diphosphonate]] (Tc-99m MDP) is the isotope of choice | ||
:*Useful for bone and cartilage tumors staging<ref name="pmid24848845">{{cite journal |vauthors=Costelloe CM, Chuang HH, Madewell JE |title=FDG PET/CT of primary bone tumors |journal=AJR Am J Roentgenol |volume=202 |issue=6 |pages=W521–31 |year=2014 |pmid=24848845 |doi=10.2214/AJR.13.11833 |url=}}</ref> | |||
:*Useful for the prognosis in some primary bone malignancies | |||
:*Useful for determining response to therapy | |||
*Common findings, include: | *Common findings, include: | ||
:*Lesions with increased uptake in any bone involved | :*Lesions with increased uptake in any bone involved | ||
==Gallery== | ==Gallery== | ||
<gallery widths="200px"> | |||
Nuclear medicine bones.jpeg| '''Bone metastases: prostate cancer'''<br>[https://en.wikipedia.org/wiki/Bone_scintigraphy <font size="-2">''Adapted from Wikipedia''</font>] | |||
</gallery> | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Up-To-Date]] | |||
[[Category:Oncology]] | |||
[[Category:Medicine]] | |||
[[Category:Rheumatology]] | |||
[[Category:Orthopedics]] | |||
Latest revision as of 02:32, 6 November 2017
|
Bone or Cartilage Mass Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Bone or cartilage mass other diagnostic studies On the Web |
|
American Roentgen Ray Society Images of Bone or cartilage mass other diagnostic studies |
|
Risk calculators and risk factors for Bone or cartilage mass other diagnostic studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Bone scintigraphy may be helpful in the diagnosis of bone and cartilage tumors. Radioisotopes play an important role in the differential diagnosis between benign and malignant bone lesions.[1][2]
Other Diagnostic Studies
Bone Scintigraphy
- Bone scintigraphy may be helpful in the diagnosis of bone and cartilage tumors
- Radioisotopes play an important role in the diagnosis of benign and malignant bone lesions[1]
- Bone scintigraphy is primarily used to help diagnose a number of conditions related to bone or cartilage masses, including: primary bone tumors, secondary bone tumors, locating some sources of bone inflammation
- Bone scintigraphy features, include:[1]
- Characterization of bone malignancy
- Characterization of pathological fractures
- Technetium-99m methylene diphosphonate (Tc-99m MDP) is the isotope of choice
- Useful for bone and cartilage tumors staging[2]
- Useful for the prognosis in some primary bone malignancies
- Useful for determining response to therapy
- Common findings, include:
- Lesions with increased uptake in any bone involved
Gallery
-
Bone metastases: prostate cancer
Adapted from Wikipedia
References
- ↑ 1.0 1.1 1.2 Focacci C, Lattanzi R, Iadeluca ML, Campioni P (1998). "Nuclear medicine in primary bone tumors". Eur J Radiol. 27 Suppl 1: S123–31. PMID 9652512.
- ↑ 2.0 2.1 Costelloe CM, Chuang HH, Madewell JE (2014). "FDG PET/CT of primary bone tumors". AJR Am J Roentgenol. 202 (6): W521–31. doi:10.2214/AJR.13.11833. PMID 24848845.